BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1317712)

  • 1. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI; Leto TL; Rotrosen D; Kwong CH; Malech HL
    Curr Opin Immunol; 1992 Feb; 4(1):53-6. PubMed ID: 1317712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
    Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The respiratory burst oxidase.
    Babior BM
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):201-12. PubMed ID: 2839456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NADPH oxidase and chronic granulomatous disease.
    Segal AW
    Mol Med Today; 1996 Mar; 2(3):129-35. PubMed ID: 8796870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood.
    Gallin JI
    Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558.
    Tsunawaki S; Mizunari H; Namiki H; Kuratsuji T
    J Exp Med; 1994 Jan; 179(1):291-7. PubMed ID: 8270871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of murine gp91phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line.
    Björgvinsdóttir H; Zhen L; Dinauer MC
    Blood; 1996 Mar; 87(5):2005-10. PubMed ID: 8634451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects.
    Morel F; Doussiere J; Vignais PV
    Eur J Biochem; 1991 Nov; 201(3):523-46. PubMed ID: 1657601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulomatous disease. Molecular genetics.
    Dinauer MC; Orkin SH
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
    Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
    Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ
    J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation mechanism of neutrophil NADPH oxidase complex--molecular pathology of chronic granulomatous disease].
    Umeki S
    Tanpakushitsu Kakusan Koso; 1994 Nov; 39(14):2284-96. PubMed ID: 7809374
    [No Abstract]   [Full Text] [Related]  

  • 14. Intersecting Stories of the Phagocyte NADPH Oxidase and Chronic Granulomatous Disease.
    Nauseef WM; Clark RA
    Methods Mol Biol; 2019; 1982():3-16. PubMed ID: 31172463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21rac does not participate in the early interaction between p47-phox and cytochrome b558 that leads to phagocyte NADPH oxidase activation in vitro.
    Kleinberg ME; Malech HL; Mital DA; Leto TL
    Biochemistry; 1994 Mar; 33(9):2490-5. PubMed ID: 8117710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F
    Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited.
    Newburger PE; Malawista SE; Dinauer MC; Gelbart T; Woodman RC; Chada S; Shen Q; van Blaricom G; Quie PG; Curnutte JT
    Blood; 1994 Dec; 84(11):3861-9. PubMed ID: 7949143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; Bolscher BG; Hilarius PM; Weening RS; Kaulfersch W; Seger RA; Roos D; Verhoeven AJ
    J Exp Med; 1994 Dec; 180(6):2329-34. PubMed ID: 7964505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.
    Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT
    N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease.
    Curnutte JT; Scott PJ; Mayo LA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):825-9. PubMed ID: 2915980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.